50 results on '"Scholl, Catharina"'
Search Results
2. Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study
3. Uncoupling of Cytochrome P450 2B6 and stimulation of reactive oxygen species production in pharmacogenomic alleles affected by interethnic variability
4. Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations
5. Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes
6. Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe
7. Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer’s disease mice
8. Targeting Cholesterol Metabolism as Efficient Antiviral Strategy Against the Hepatitis E Virus
9. Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry
10. Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease mice
11. Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain
12. Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients
13. Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity
14. List of Contributors
15. Companion Diagnostics and Biomarker Tests in the European Medicines Agency’s Assessment of Medicinal Products
16. Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations
17. Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe
18. Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial
19. Catch me if you can – the crosstalk of ZIKV and the restriction factor Tetherin
20. Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)–Never Change a Running System?
21. Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe
22. Association between miRNA signatures in serum samples from epidermal growth factor inhibitor treated patients and skin toxicity
23. CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study
24. Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain
25. Impact of Zika Virus Infection on Human Neural Stem Cell MicroRNA Signatures
26. A fast and efficient polymerase chain reaction-based method for the preparation of in situ hybridization probes
27. Chapter 17 - Companion Diagnostics and Biomarker Tests in the European Medicines Agency’s Assessment of Medicinal Products
28. Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study
29. Green tea extract to prevent colorectal adenomas in men and women: Results of the MIRACLE trial.
30. Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity
31. Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain
32. Adverse Drug Reactions (ADR) and Emergencies: The Prevalence of Suspected ADR in Four Emergency Departments in Germany
33. Adverse Drug Reactions (ADR) and Emergencies
34. Population nutrikinetics of green tea extract
35. Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash
36. Dosing to rash? – The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash
37. Gene regulatory biomarker identification for skin toxicities induced by EGFR inhibitor treatment
38. High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors
39. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study
40. Identifizierung und Charakterisierung kleiner nicht-kodierender RNA Moleküle aus dem Zellkern muriner Embryonaler Stammzellen und Embryonic Bodies
41. Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients
42. Faculty Opinions recommendation of Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
43. Proliferation and cilia dynamics in neural stem cells prospectively isolated from the SEZ
44. Zonation of Nitrogen and Glucose Metabolism Gene Expression upon Acute Liver Damage in Mouse
45. Faculty Opinions recommendation of Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
46. Indirubin Derivatives Modulate TGFβ/BMP Signaling at Different Levels and Trigger Ubiquitin-Mediated Depletion of Nonactivated R-Smads
47. Real-Time Monitoring of Cisplatin-Induced Cell Death
48. Catch Me if You Can: the Crosstalk of Zika Virus and the Restriction Factor Tetherin.
49. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study
50. Association of Polymorphic Cytochrome P450 Enzyme Pathways With Falls in Multimedicated Older Adults.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.